Repositioning food and drug administration-approved drugs for inhibiting biliverdin IXβ reductase B as a novel thrombocytopenia therapeutic target.

This item is discarded!Release HistoryDetailsSummary

Repositioning food and drug administration-approved drugs for inhibiting biliverdin IXβ reductase B as a novel thrombocytopenia therapeutic target.

Kim, M., Ha, J.-H., Choi, J., Kim, B.-R., Gapsys, V., Lee, K. O., et al. (2022). Repositioning food and drug administration-approved drugs for inhibiting biliverdin IXβ reductase B as a novel thrombocytopenia therapeutic target. Journal of Medicinal Chemistry, 65(3), 2548-2557. doi:10.1021/acs.jmedchem.1c01664.

Item is Discarded

Basic (Discarded)

Date of Discard: 2022-09-26

Comment: Dublette

Creators:
Kim, M.
Ha , J.-H.
Choi, J.
Kim, B.-R.
Gapsys, V.¹
Lee, K. O.
Jee, J.-G.
Chakrabarti, K. S.
de Groot, B. L.¹
Griesinger, C.²
Ryu, K.-S.
Lee, D.

Affiliations:
1Department of Theoretical and Computational Biophysics, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society, ou_3350132
2Department of NMR Based Structural Biology, Max Planck Institute for Multidisciplinary Sciences, Max Planck Society, ou_3350124

Dates: Submitted: 2021-11-18Published Online: 2021-12-27Date issued: 2022-01-25

Files: 1 File

Locators: 0 Locators

version ID: item_3377764_2

Item State: Discarded

Name of Context: Publications of the MPI for Multidisciplinary Sciences, Affiliated to: Max Planck Institute for Multidisciplinary Sciences